PAA 4.88% 21.5¢ pharmaust limited

Ann: Following Extension of Survival, PAA Prepares Phase 3 Trial, page-61

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,453 Posts.
    lightbulb Created with Sketch. 1179
    "Elanco's decision in 2020 to pull out its dog option and take back its monepantel supply, forcing PAA to come up with its own gmp monepantel,"

    Is that correct? Did Elanco take back its MPL supply? as I recall the GMP MPL they provided was for dog use only do not recall of GMP MPL but it would not be the first time I have been wrong!

 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.